Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder

Abstract

Several placebo-controlled trials have shown the effcacy of clomipramine (CMI) in panic disorder. However, none has investigated the relationship between CMI, and desmethylclomipramine (DCMI) plasma levels, and outcome. In this trial, 41 patients meeting the DSM-III-R criteria for panic disorder with/without agoraphobia received 50-200 mg of CMI daily in a single-blind, flexible dose regimen for 14 weeks. At the end of treatment, 97% of the patients were free of panic attacks. Patients were classified into two groups of improvement according to the panic symptom items of the `Patient-Rated Anxiety Scale'. A repeated-measures analysis of variance suggested a significant association between outcome and serum DCMI level/daily dose ratio as well as total serum level/daily dose. Patients with intense improvement showed DCMI and total serum levels lower than those with moderate improvement. The results indicate the importance of monitoring clomipramine and desmethylclomipramine serum levels in this disorder.

Keywords

clomipramine desmethylclomipramine panic disorder plasma levels

Get full access to this article

View all access options for this article.

References

American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd rev. edn. American Psychiatric Press, Washington, DC

Beck A T , Luand C H , Mendelson M , Mock J , Erbaugh J (1961) An inventory for measuring depression . Arch Gen Psychiatr 4: 53-61

Broadhurst A D , James H D , Della Corte L , Heeley A F (1977) Clomipramine plasma levels and clinical response . Postgrad Med J 53 (Suppl. 4): 139-145

Brunello N , Langer S Z , Perez J , Racagni G (1995) Current under-standing of the mechanism of action of classic and newer antidepressant drugs . Depression 2: 119-126

Charney D S , Heninger G R (1985) Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment . Arch Gen Psychitr 42: 473-481

Delgado P L , Gelenberg A J (1995) Antidepressant and antimanic medications. In: Gabbard G O (ed.), Treatments of psychiatric disorders. American Psychiatric Press, Washington, DC

Della Corte L , Broadhurst A D , Sgaragli G P , Filipini S , Heeley A F , James H D , Faravelli C , Pazzagli A (1979) Clinical response and tricyclic plasma levels during treatment with clomipramine . Br J Psychiatr 134: 390-400

Faravelli C , Broadhurst A D , Ambonetti A , Ballerini A , De Biase L , La Malfa G , Das M (1983) Double-blind trial with oral versus intravenous clomipramine in primary depression . Biol Psychiatr 18: 695-706

Faravelli C , Ballerine A , Ambonetti A , Broadhurst A D , Das M (1984) Plasma levels and clinical response during treatment with clomipramine . J Affect Disord 6: 95-107

10.

Gentil V (1986) Fisiopatologia da sndrome do panico . Rev Assoc Med Brasil 32: 121-127

11.

Gentil V , Lotufo-Neto F , Andrade L , Cordas T , Bernik M , Ramos R , Maciel L , Miyakawa E , Gorenstein C (1993) Clomipramine, a better reference drug for panic/agoraphobia. I. effectiveness comparison with impramine . J Psychopharmacol 7: 316-324

12.

Greenblatt D J , Harmatz J S , Shader R I (1993) Plasma alprazolam concentrations. Relation to effcacy and side-effects in the treatment of panic disorder . Arch Gen Psychiatr 50: 715-722

13.

Guy W (1976) ECDEU assessment manual for psychopharmacology, revised. NIMHANS 76/338, pp. 217-222. US Government Printing Offce, Washington, DC

14.

Guyon F , Ni P , Jezequiel M , Dupeyron J P (1987) Dosage de la clomipramine et de son derive demethyle par chromatografie en phase liquide . Ann Biol Clin 45: 157-159

15.

Hullin R P (1980) Variation in plasma concentrations of clomipra-mine and desmethylclomipramine during clomipramine therapy . Postgrad Med J 56 (Suppl. 1): 117-119

16.

Linnoila M , Seppala T , Mattila M J , Vihko R , Pakarinen A , Skinner J T (1980) Clomipramine and doxepine in depressive neurosis . Arch Gen Psychiatr 37: 1295-1299

17.

Lotufo-Neto F , Gentil V , Bernik M , Ramos, R , Cordas, TA , Goren-stein C , Melo, M , Andrade L (1994) Clomipramine double-blind discontinuation in panic disorder patients . Neuropsychopharmacology 10: 11S-11S

18.

Modigh K (1987) Antidepressant drugs in anxiety disorders Acta Psychiatr Scand 76 (Suppl. 335): 57-74

19.

Noguchi T , Shimoda K , Takahashi S (1993) Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data . J Affect Disord 29: 267-279

20.

Pascalis G , Wargny E , Lamiable D , Havet J M (1987) Clomipramine et demethylclomipramine . Correlation taux plasmatique/effcacite chez 24 deprimes. Encephale 13: 239-244

21.

Piollet I , Goyot C , Paire M , Touzery A , Eschalier A , Dehennin L , Grenier J , Lavarenne J , Zarafian E (1988) Etude des concentration plasmatique de la clomipramine et de son derive demetile chez l'homme . Limites methodologiques. Encephale 14: 287-292

22.

Reisby N , Gram F , Beck F , Sihm F , Krautwald O , Elley J , Ortmann J , Christiansen J (1979) Clomipramine: plasma levels and clinical effect . Commun Psychopharmacology 3: 341-351

23.

Sheehan DV (1983) The anxiety disease. Charles Schriber's Sons, New York

24.

Traskman L , Asberg M , Bertilsson L , Cronholm B , Mellstrom B , Neckers L M , Sjoqvist F , Thoren P , Tybring G (1979) Plasma levels of clomipramine and its demethyl metabolite during treatment of depression . Clin Pharmacol Ther 26: 600-610

25.

Vandel B , Vandel S , Jounet J M , Allers G , Volmat R (1981) Clomipra-mine et desmethylclomipramine . Relation entre les concentration plasmatique et l'effet clinique. Encephale VII: 601-608

26.

Vandel B , Vandel S , Jounet J M , Allers G , Volmat R (1982) Relation-ship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response . Eur J Clin Pharmacol 22: 15-20

27.

Wargny E , Lamiable D , Havet J M , Denis J , Milliart H , Choisy H , Pascalis G (1986) Concentrations plasmatiques de clomipramine et de declomipramine chez des patients atteints de depression: recherche de correlation avec l'effcacite therapeutique . Ann Med Psychol (Paris) 144: 396-406